1. IL-6: The Link Between Inflammation, Immunity and Breast Cancer
   Juan Chen et al, 2022, Frontiers in Oncology CrossRef
2. tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A)
   Zhengxiang Zhang et al, 2022, Bioengineered CrossRef
3. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
   Camilla Coulson‐Gilmer et al, 2018, The Journal of Pathology: Clinical Research CrossRef
4. Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
   Mariam Abotaleb et al, 2018, Biomedicine & Pharmacotherapy CrossRef
5. Identifying and analyzing different cancer subtypes using RNA-seq data of blood platelets
   Yu-Hang Zhang et al, 2017, Oncotarget CrossRef
6. Integrated Chip-Seq and RNA-Seq Data Analysis Coupled with Bioinformatics Approaches to Investigate Regulatory Landscape of Transcription Modulators in Breast Cancer Cells
   Jairo Ramos et al, 2020, Molecular Toxicology Protocols CrossRef
7. Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajan in breast cancer cells
   Yujie Fu et al, 2015, Phytomedicine CrossRef
8. Moonlight human ribosomal protein L13a downregulation is associated with p53 and HER2/neu expression in breast cancer
   Ghader Molavi et al, 2020, Journal of Applied Biomedicine CrossRef
9. Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme
   EVA BLAHOVCOVA et al, 2015, International Journal of Molecular Medicine CrossRef
10. Microfluidic profiling of apoptosis-related genes after treatment with BH3-mimetic agents in astrocyte and glioblastoma cell lines
    Eva Vidomanova et al, 2016, Oncology Reports CrossRef